CAS: 314-35-2; 7-(2-(Diethylamino)Ethyl)-1,3-Dimethyl-3,7-Dihydro-1H-Purine-2,6-Dione

该化合物是一种化学化合物,被归类为支气管,主要用于治疗哮喘和慢性阻塞性肺病等呼吸系统疾病(COPD),通过放松空气道的光滑肌肉发挥作用,从而方便呼吸;该物质以其抗沙司摩底特性而著称,有助于缓解支气管炎;从化学角度讲,亚马西林是一种衍生物,它展示了一种结构,使它能与登氧素受体发生相互作用,有助于其治疗效果;它通常以口服形式施用,并可在各种药剂中找到;该化合物在水中具有中溶性,在标准条件下保持稳定;与许多药物一样,其潜在副作用可能包括胃肠紊乱,...

结构式图片

MSDS等安全信息

    上下游产品

    茶碱 Theophylline 58-55-9

    合成工艺路线路线简述

      📜茶碱,N,N-二乙基氯乙胺置于异丙醇体系中,化学反应生成 7-[2-(二乙氨基)乙基]-1,3-二甲基黄嘌呤
      参考文献:Beitrag Zur Reaktionsfähigkeit Der 7-Stellung Des Theophyllins. 2. Mitt. über Synthesen In Der Theophyllinreihe
      标题:Beitrag Zur Reaktionsfähigkeit Der 7-Stellung Des Theophyllins. 2. Mitt. über Synthesen In Der Theophyllinreihe
      摘要:
      DOI:10.1002/ardp.19552880702

      海关参考信息

      专利信息


      专利号:US-2004005342-A1
      优先权日:2002-02-07
      标题 :Topical administration of ascorbic acid to reinforce the cohesion of the dermo-epidermal junction
      发明人:BERNERD FRANCOISE
      权利人:OREAL
      摘要:The present invention relates to the pharmaceutical or cosmetic use of a composition comprising, in a pharmaceutically or cosmetically acceptable medium, ascorbic acid or an analogue thereof to reinforce the cohesion of the dermo-epidermal junction. n The invention also relates to the pharmaceutical or cosmetic use of a composition comprising, in a pharmaceutically or cosmetically acceptable medium, ascorbic acid or an analogue thereof to increase the synthesis of tenascin and/or collagen VII. n The invention also relates to the use of ascorbic acid or of an analogue thereof to reinforce the cohesion of the dermo-epidermal junction of reconstructed skins.

      专利号:US-8858968-B2
      优先权日:2005-12-05
      标题 :Use of tyrosine-arginine dipeptide and niacinamide as substance P antagonist
      发明人:POTIN ANTHONY
      权利人:POTIN ANTHONY; OREAL
      摘要:Use of the combination of the tyrosine-arginine dipeptide or derivatives thereof and of niacinamide as a substance P antagonist for treating red blotches on the skin, skin oedema and sensitive skin. Use of this combination for the preparation of a composition for use in treating disorders associated with an excess synthesis and/or release of substance P.

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      主要参考文献


      1: Vázquez C, Labayru MT. Un estudio comparativo del efecto de una dosis oral única de teofilina y de etamifilina en niños con asma [Comparative study of the effect of a single oral dose of theophylline and etamiphyllin in children with asthma]. An Esp Pediatr. 1984 Nov 30;21(8):739-46. Spanish. 94(24):560-1. doi: 10.1136/vr.94.24.560. 2(6):271-7. doi: 10.1002/dta.133. 25(1):43-8. doi: 10.1046/j.1365-2885.2002.00383.x. 1(8385):1083. doi: 10.1016/s0140-6736(84)91497-1. 36(5):1085-91. doi: 10.1016/j.jpba.2004.09.005. 1(8382):914. doi: 10.1016/s0140-6736(84)91380-1. 9(3):201. doi: 10.1177/096032719000900316. 6(3):237-46. Spanish. 104(1):22. doi: 10.1136/vr.104.1.22.

      合成参考文献


      摘要:Arzneimittel-Forschung. Drug Research., 4(649), 1954 []
      摘要:S72 | NTUPHTW | Pharmaceutically Active Substances from National Taiwan University | DOI:10.5281/zenodo.3955664
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知